DYRK1A suppression attenuates HIF-1α accumulation and enhances the anti-liver cancer effects of regorafenib and sorafenib under hypoxic conditions

por Zhang, Chong, Wu, Lin-Wen, Li, Zhi-Di, Zhang, Man-Man, Wu, Jie, Du, Fei-Hua, Zeng, Ling-Hui, Li, Yang-Ling
Publicado 2022